Cytologics Revenue and Competitors
Estimated Revenue & Valuation
- Cytologics's estimated annual revenue is currently $930k per year.
- Cytologics's estimated revenue per employee is $155,000
Employee Data
- Cytologics has 6 Employees.
- Cytologics grew their employee count by -45% last year.
Cytologics's People
Name | Title | Email/Phone |
---|
Cytologics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Cytologics?
Cytologics specializes in customized procurement of human-derived biological products and services for biomedical research, drug discovery and cellular therapy process development. The Company’s supplier network of FDA-registered, GMP-compliant blood collection centers ensures fresh donor material is available to customers from the Cytologics isolation laboratory. Human biological material, including peripheral blood, is isolated into various primary cell types and proteins for fresh and frozen distribution to life science customers. We make it easy to find the right cells to advance your research. All products are well-characterized, tested for blood borne pathogens and guaranteed for cell viability and purity. We also offer a wide range of research services to support your basic and translational research activities.
keywords:N/AN/A
Total Funding
6
Number of Employees
$930k
Revenue (est)
-45%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.7M | 6 | -25% | N/A |
#2 | $0.4M | 6 | N/A | N/A |
#3 | $0.4M | 6 | N/A | N/A |
#4 | $0.4M | 6 | N/A | N/A |
#5 | $0.4M | 6 | N/A | N/A |